The active ingredient in turmeric, curcumin, helps combat inflammation and offers numerous health benefits. Apart from medicinal use, turmeric lends flavor and color to a variety of dishes.

Turmeric’s skin-brightening properties are widely recognised for treating hyperpigmentation and irregular skin tone. Its primary ingredient, curcumin, inhibits melanin formation, significantly ...

One of the biotech in­dus­try’s most well-fund­ed cell and gene ther­a­py com­pa­nies has laid off em­ploy­ees for the third year in a row.

Turmeric gets its anti-inflammatory and antioxidant properties from a natural compound, or polyphenol, called curcumin. “It is also rich in phytochemicals which can have protective health benefits to ...

WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the significant, global integration of the biomedical ...

Boston-based Hill­star Bio on Tues­day be­came the lat­est im­munol­o­gy start­up launch, un­veil­ing a $67 mil­lion Se­ries A round ...

Hillstar Bio is revolutionizing autoimmune disease treatment through a precision-driven approach that selectively depletes pathogenic cells while preserving healthy ones. This method holds the promise ...

Adding a pinch of black pepper can significantly increase the bioavailability of curcumin, the main active component of turmeric. Curry is a dish made with a sauce heavily seasoned with spices ...

Curcumin, the active compound in turmeric, enhances the effectiveness of the antibiotic bedaquiline in fighting M. abscessus infections Combining curcumin with bedaquiline prevents bacteria from ...

In the latest move to cement its “immunology powerhouse” status, Sanofi is handing over $600 million upfront for Dren Bio’s clinical-stage bispecific antibody, with more than $1 billion in ...

For the unversed, turmeric and pepper should be consumed together to have a better absorption of curcumin. Curcumin is a compound found in turmeric. It is known to be super-healthy, however it is ...

March 20 (Reuters) - Sanofi (SASY.PA), opens new tab on Thursday announced an agreement with biopharmaceutical company Dren Bio for the acquisition of its autoimmune disease treatment DR-0201.